NASDAQ · Stocky rates: Hold

Roche Holding AG (RHHVF)

$468.60 ▲ +2.20% as of 21 Aug, 00:00

Stocky turns companies like Roche Holding AG into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
60
/ 100
Hold

What Stocky thinks

Hold. RHHVF earns a middling compounder score (55.8 growth, 60 value) reflecting modest operational momentum without pricing power or structural advantage. Leadership alignment is weak (52/100), suggesting misaligned incentives or dilution concerns. Most concerning: a Vulnerability Index of 100 signals reliance on financial buffer alone—no durable moat protects against competitive or operational shocks. Reasonable valuation at 16.9× forward P/E doesn't offset the structural fragility.

Compounder Score
60/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
52/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
100/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
60/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for Roche Holding AG:

60
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 60/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

52
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

100
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

Roche Holding AG (RHHVF) — frequently asked

Is Roche Holding AG (RHHVF) a good investment right now?

Stocky rates Roche Holding AG (RHHVF) at 60/100 — a Hold — quality is solid but valuation or risk factors cap upside. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Hold. RHHVF earns a middling compounder score (55.8 growth, 60 value) reflecting modest operational momentum without pricing power or structural advantage. Leadership alignment is weak (52/100), suggesting misaligned incentives or dilution

What is RHHVF's Stocky Verdict?

RHHVF's current Stocky Verdict is 60/100, placing it in the "Hold" band. This composite combines a 60/100 Compounder score, 52/100 Leadership, Moat rating, and analyst signal.

Does Roche Holding AG have a competitive moat?

Stocky hasn't finalised a Moat Score for Roche Holding AG yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is Roche Holding AG's leadership aligned with shareholders?

Roche Holding AG scores 52/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to RHHVF?

Roche Holding AG's Vulnerability Profile scores 100/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to Roche Holding AG.

This is just the surface. See the whole picture on Roche Holding AG.

Sign up free and unlock the full analysis on RHHVF — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering RHHVF — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for RHHVF.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how RHHVF changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to RHHVF?" · "Is RHHVF overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
60
/ 100 · Hold

See Roche Holding AG the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in RHHVF would be worth today.
Practice portfolio
Buy RHHVF with virtual money and track it — zero risk.
Free · no real money · learn by doing Open RHHVF in Stocky →

Or jump straight to the interactive dashboard for RHHVF in the app.